New York
Phase 2 colorectal cancer trials in New York
18 Phase 2 colorectal cancer studies are recruiting participants at sites in 14 cities across New York as of November 18, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every New York city with a recruiting study
New York (16), Commack (7), Harrison (6), Lake Success (3), Rockville Centre (3), Uniondale (3), Brooklyn (1), Flushing (1), Forest Hills (1), Greenlawn (1), Mount Kisco (1), Rego Park (1), Sleepy Hollow (1), Valhalla (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Recently updated studies in New York
Basic details from each study's public record (the 12 most recently updated of 18). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Verastem, Inc.
- Recruiting in
- New York
- Registry record
- NCT07659795 · updated
A Study of Tucatinib and Trastuzumab in People With Rectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Recruiting in
- Commack · Harrison · New York · and 1 more U.S. location
- Registry record
- NCT05672524 · updated
A Study of Retifanlimab After Chemoradiation in People With Anal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Recruiting in
- Commack · Harrison · New York · and 1 more U.S. location
- Registry record
- NCT07927998 · updated
Tislelizumab in People With Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Recruiting in
- New York
- Registry record
- NCT06529523 · updated
Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Recruiting in
- Commack · Harrison · New York · and 1 more U.S. location
- Registry record
- NCT04165772 · updated
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Jazz Pharmaceuticals
- Recruiting in
- Lake Success · New York
- Registry record
- NCT06695845 · updated
Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Columbia University
- Recruiting in
- New York
- Registry record
- NCT07433673 · updated
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Alliance for Clinical Trials in Oncology
- Recruiting in
- Brooklyn · Commack · Flushing · and 10 more U.S. locations
- Registry record
- NCT05673148 · updated
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Criterium, Inc.
- Recruiting in
- New York
- Registry record
- NCT06992258 · updated
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Recruiting in
- Lake Success
- Registry record
- NCT07023289 · updated
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Phase 2
- Ages 18 to 130
- All sexes
- Sponsor
- AstraZeneca
- Recruiting in
- Commack
- Registry record
- NCT05489211 · updated
A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Recruiting in
- Commack · Harrison · New York · and 1 more U.S. location
- Registry record
- NCT07227636 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in New York on ClinicalTrials.gov.
Ask about studies in New York
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 2, as each study is coded in the registry.
Colorectal Phase 2 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections